Description
Bios-3p is a novel, investigational peptide that acts as a triple agonist for the glucagon (GCG), glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1) receptors. This multi-receptor agonism allows Retatrutide to influence a range of metabolic pathways. Its mechanism of action involves stimulating insulin secretion, suppressing glucagon release, delaying gastric emptying, and promoting satiety, which collectively contribute to improved glycemic control and significant weight reduction. Primary research areas for Retatrutide include the treatment of obesity and type 2 diabetes. Clinical studies have demonstrated its potential to achieve substantial weight loss and improve metabolic markers. Further research is exploring its effects on related conditions such as non-alcoholic fatty liver disease (NAFLD) and cardiovascular risk factors. This product is intended for laboratory research use only. It is not for human or veterinary use. Researchers should handle this product in accordance with established laboratory safety protocols.
CAS: 2381089-83-2
PubChem CID: 171390338
Molecular Formula: C221H342N46O68
Molecular Weight: 44731.33 g/mol
Amino Acid Sequence: Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-αMeLeu-Leu-Asp-Lys-Lys(γ-Glu-C20 diacid)-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2
Physical Form: Lyophilized Powder
Purity: ≥99%
Storage: -20°C, protected from light and moisture



















